Can Ozempic help lower your risk of dementia?

Translate to Spanish or other 102 languages!

According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030. Image for illustration purposes
According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030. Image for illustration purposes
- Advertisement -

Medical News Today

  • There are several risk factors for dementia, including type 2 diabetes and obesity. 
  • A new study reports that semaglutide — the active ingredient in GLP-1 medications Ozempic and Wegovy for type 2 diabetes and weight loss — may help lower dementia risk in people with type 2 diabetes. 
  • Researchers say semaglutide targets several dementia risk factors and is anti-inflammatory, which could explain this benefit to brain health.

According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030.

Follow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/can-ozempic-weight-loss-diabetes-help-lower-risk-vascular-dementia?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-07-23&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -